Australian Biotech Firm Vincent+ Navigates U.S. Tariff Fallout as Australia Post Suspends U.S. Shipments
Vincent+, an Australian biotech company, faces shipping disruptions and potential cost increases due to new U.S. tariffs that prompted Australia Post to suspend parcel services to the United States, highlighting challenges for global trade and small exporters.
